Low-dose Angiotensin II Infusion Restores Vascular Function in Cerebral Arteries of High Salt-fed Rats by Increasing Copper/zinc Superoxide Dimutase Expression
Overview
Authors
Affiliations
Background: This study examined the vasoprotective role of circulating angiotensin II (ANG II) levels in the cerebral circulation of high salt (HS)-fed (SS.BN-(D13hmgc41-13hmgc23)/Mcwi) (Ren1-BN) congenic rats, which carry a normally functioning renin allele from the Brown Norway (BN) rat on the Dahl salt-sensitive genetic background.
Methods: Ren1-BN rats were placed on an HS (4.0% NaCl) diet for 3 days. The vasodilator response to acetylcholine (ACh; 10(-10) - 10(-6) mol/L) was assessed in isolated middle cerebral arteries (MCAs), and Western blots were performed to assess the expression of the antioxidant enzymes copper (Cu)/zinc (Zn) superoxide dismutase (SOD) and manganese (Mn) SOD in cerebral resistance vessels. A separate group of HS-fed animals were infused with either a subpressor dose of ANG II (100ng/kg/min) or saline vehicle via osmotic minipump for 3 days.
Results: HS diet eliminated acetylcholine (ACh)-induced dilation in the MCAs of the congenic rats. Western blot analysis of antioxidant enzymes showed that Cu/Zn SOD and Mn SOD expression were significantly reduced in the cerebral resistance arteries of the HS-fed rats compared with control animals fed a normal salt diet. Infusion of ANG II restored the vasodilator response to ACh in the MCAs and increased Cu/Zn SOD (but not Mn SOD) expression compared with saline-infused animals.
Conclusions: These results indicate that prevention of salt-induced ANG II suppression prevents vascular dysfunction in the cerebral circulation by preventing the downregulation of Cu/Zn SOD and vascular oxidant stress that normally occurs with HS diet.
Kolobaric N, Kozina N, Mihaljevic Z, Drenjancevic I Biomedicines. 2025; 12(12.
PMID: 39767646 PMC: 11726729. DOI: 10.3390/biomedicines12122741.
Salty Subjects: Unpacking Racial Differences in Salt-Sensitive Hypertension.
Jeong S, Hunter S, Cook M, Grosicki G, Robinson A Curr Hypertens Rep. 2023; 26(1):43-58.
PMID: 37878224 PMC: 11414742. DOI: 10.1007/s11906-023-01275-z.
Watso J, Fancher I, Gomez D, Hutchison Z, Gutierrez O, Robinson A Obes Rev. 2023; 24(8):e13589.
PMID: 37336641 PMC: 10406397. DOI: 10.1111/obr.13589.
Lukaszewicz K, Falck J, Lombard J Antioxidants (Basel). 2023; 12(4).
PMID: 37107157 PMC: 10135295. DOI: 10.3390/antiox12040783.
Ertuglu L, Pitzer Mutchler A, Yu J, Kirabo A Front Physiol. 2023; 13:1096296.
PMID: 36620210 PMC: 9814168. DOI: 10.3389/fphys.2022.1096296.